GNA Biosolutions
Latest round
- Series C
Last raised
- Aug 2019
Total raised
- $20M
Investors
- 9
About GNA Biosolutions
Founded in 2010 and based in Germany, GNA Biosolutions GmbH is a company that develops pulse controlled amplification (PCA) assays and instruments for detection of biomolecules. The PCA technology the company develops makes the molecular testing process simpler than the conventional molecular testing.
Who invested in GNA Biosolutions
9 investors across 2 rounds
See all investors in GNA Biosolutions
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GNA Biosolutions
Who invested in GNA Biosolutions?
GNA Biosolutions has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GNA Biosolutions raised?
GNA Biosolutions has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did GNA Biosolutions last raise money?
GNA Biosolutions's most recent round on record is a Series C, in Aug 2019.
What does GNA Biosolutions do?
Founded in 2010 and based in Germany, GNA Biosolutions GmbH is a company that develops pulse controlled amplification (PCA) assays and instruments for detection of biomolecules.
Where is GNA Biosolutions headquartered?
GNA Biosolutions is headquartered in Germany.
Which VCs invest in companies like GNA Biosolutions?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at GNA Biosolutions's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like GNA Biosolutions? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.